Metabolomics in various Diseases

Metabolomics is new omics platform that offers great potential for the diagnosis and prognosis of neurodegenerative diseases as an individual metabolome reflects alterations in genetic, transcript, and protein profiles and effects from the environment. Small numbers of metabolites have been used to diagnose complex metabolic diseases as well as monogenic disorders such as inborn errors of metabolism. Metabolic alterations in Cardiopulmonary Vascular Dysfunction are the leading purpose of death worldwide which is affecting the functions of the blood vessels and heart.

 

    Related Conference of Metabolomics in various Diseases

    July 17-18, 2020

    10th Glycobiology World Congress

    Vienna, Austria
    August 03-04, 2020

    12th Euro Biosensors & Bioelectronics Congress

    Zurich, Switzerland
    September 22-23, 2020

    International Conference on Nucleic Acids

    Dubai, UAE
    September 28-29, 2020

    2nd International Conference on Metabolomics, Genomics and Proteomics

    Singapore City, Singapore
    September 28-29, 2020

    19th International Conference on Structural Biology

    Barcelona, Spain
    September 29-30, 2020

    World Congress on Biosensors and Bioelectronics

    Osaka, Japan
    October 21-22, 2020

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 07-08, 2020

    9th World Congress on Glycobiology & Glycochemistry

    Dubai, UAE
    December 10-11, 2020

    2nd Pathology and Infectious Disease Conference

    Dubai, UAE
    April 01-02, 2021

    12th Tissue Science and Regeneration Congress

    Abu Dhabi, UAE
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic

    Metabolomics in various Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in